to expand the scope of the program by re-introducing the manufacture and distri
Closed
Pre-solicitation
WOSB set-aside
NAICS 541715
| Agency | |
| Place of performance | See the notice |
| Type of notice | Pre-solicitation |
| Set-aside | SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15) |
| Response deadline | Not given |
| Posted | Aug 3, 2018 |
| Solicitation number | 75N92018R0070 |
| NAICS code | 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
Summary from the notice
The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by re-introducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
Other open NAICS 541715 notices
Details copied from the public SAM.gov notice. BidFox is not connected to SAM.gov or the U.S. Government, so check the official notice before you bid.